Track topics on Twitter Track topics that are important to you
Lineage Cell Therapeutics (NYSE American:LCTX, TASE:LCTX) has announced that the US Patent and Trademark Office (USPTO) has issued US Patent No. 10,344,262 for a system to produce antigen presenting dendritic cells from human embryonic stem cells (hESCs). As quoted in the press release: The claimed system and cell populations involve culturing cells in a serum-free … Continued
The post Lineage Cell Therapeutics Receives US Patent for Immunogenic Dendritic Cells Generating System appeared first on Investing News Network.NEXT ARTICLE
Track and monitor developments in stem cell research and commercial development. Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry. BioPort...